Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Pexels / Pixabay

Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients

According an article from CityNews Toronto, an anti-psychotic medication is undergoing clinical trials in the treating of amyotrophic lateral sclerosis. In other studies, the treatment has shown to help slow…

Continue Reading Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
The First Treatment in History for Mucopolysaccharidosis VII Was Just Approved by the FDA
source: pixabay.com

The First Treatment in History for Mucopolysaccharidosis VII Was Just Approved by the FDA

According to a story from EParent, the pharmaceutical company Ultragenyx released a statement confirming that the company's product MEPSEVII had received approval for public use by the Food and Drug…

Continue Reading The First Treatment in History for Mucopolysaccharidosis VII Was Just Approved by the FDA
PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis
source: pixabay.com

PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis

According to a story from CBC News, Jillian Lanthier's son Landen Alexa was diagnosed with a severe and rare form of juvenile idiopathic arthritis at six years old. Although he…

Continue Reading PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis
This Tournament is Raising Money for Colitis and Crohn’s Disease Research
source: pixabay.com

This Tournament is Raising Money for Colitis and Crohn’s Disease Research

According to a story from Syosset Jericho Tribune, the charity basketball fundraiser called Hoops for Harrison is back again this year. The tournament was named after Harrison Gillman, who now…

Continue Reading This Tournament is Raising Money for Colitis and Crohn’s Disease Research
A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA
source: pixabay.com

A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA

According to a story from ANCA Vasculitis News, The European Medicines Agency just approved the pharmaceutical company ChemoCentryx's application for the marketing of avacopan as a potential treatment for anti-neutrophil…

Continue Reading A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA
These Researchers Have Discovered The Truth About Idiopathic Pulmonary Fibrosis
source: pixabay.com

These Researchers Have Discovered The Truth About Idiopathic Pulmonary Fibrosis

New research is helping experts understand the underlying causes of idiopathic pulmonary fibrosis on the molecular scale. When solving any problem, disease included, it is best to start by understanding…

Continue Reading These Researchers Have Discovered The Truth About Idiopathic Pulmonary Fibrosis
New Bathroom Changes The Game For Family Fighting Rare Disease and Cancer
tookapic / Pixabay

New Bathroom Changes The Game For Family Fighting Rare Disease and Cancer

Margarita Matias could not believe her eyes when she walked into the newly renovated bathroom. Her old bathroom was far from ideal, and often leaked. The new arrangement is optimized…

Continue Reading New Bathroom Changes The Game For Family Fighting Rare Disease and Cancer